NEW YORK (GenomeWeb Daily News) – The Southwest Michigan First Life Science Fund said this week that it has invested an undisclosed amount in RealBio Technology to support the commercialization of its cell and tissue culture technology for drug discovery and life science research.

Other investors include stem-cell therapy firm Aastrom Biosciences and First Angels, a Kalamazoo-based angel investor group. RealBio also has received funding from the Michigan Pre-Seed Microloan Program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.